Generic Semaglutide vs Ozempic: Same Medicine, New Maker, Lower Price

Comparing generic semaglutide vs Ozempic because your plan or pharmacist offered a switch? The short answer: the medicine in the pen is the same molecule.

The longer answer is about how it is made, which pen you get and what your plan pays for. This page walks through each difference, using Health Canada’s own documents.

We read the Canadian product monographs for Apo-Semaglutide and Ozempic when this page was built, and every pen detail below comes from them. Price numbers come from public formularies, news reports, a published August 2026 retail audit and labelled estimates.

Is generic semaglutide the same as Ozempic?

Yes, for the active ingredient and the doses up to 1 mg. Health Canada’s word is “pharmaceutically equivalent”, and it comes with a caveat worth reading.

In its first approval notice, Health Canada called the generics complex synthetic products. It said their differences from the brand were reviewed to make sure they “do not affect the safety, efficacy, or quality” of the medicine.¹

The first generic, from Dr. Reddy’s, was authorized on April 28, 2026, and Health Canada said that review finished within its 180-day target.^1,2 Apotex followed on May 1, 2026.²

So the honest framing is this: same drug substance, judged equivalent, made a different way. If price is what pushed you here, our generic semaglutide price comparison lists what each pharmacy charges.

Generic semaglutide vs Ozempic side by side

The table below puts the two next to each other. Everything in it comes from Health Canada’s databases and the product monographs.^2,3,4

Two rows deserve a second look. The approved-uses row differs because Ozempic’s monograph carries heart and kidney risk-reduction indications, and its indications section was last revised in February 2026.

The Apo-Semaglutide monograph lists blood sugar control only.^3,4 The dose row differs because no generic company makes a 2 mg pen.

How Health Canada judged the generics

Each generic was reviewed against Ozempic. Health Canada authorized it only once the maker showed its differences do not change safety, efficacy or quality.¹ That is a real check, but it is not a new set of patient trials.

The regulator’s route tells you a lot. Ozempic was authorized in 2018 through a New Drug Submission and is classed as a biologic. Each generic was authorized through an Abbreviated New Drug Submission and classed as a prescription pharmaceutical.²

Health Canada has also been open about the limits. A synthetic copy can have “possible differences that could impact safety and efficacy”, and the maker has to show they do not.^5,1 That is the caveat behind the word “equivalent”.

What the monographs show

The generic monograph borrows Ozempic’s evidence. The trial section in the Apo-Semaglutide monograph carries the heading “Clinical Trials – Reference Biologic Drug” and describes Novo Nordisk’s SUSTAIN studies.³ The side-effect tables in the two monographs print the same numbers, because they come from the same Ozempic trials.^3,4

What is not public

Did Health Canada require studies comparing blood levels of the generic and the brand in people? It has not said so publicly.

We found no such study published by a generic maker either. We could not find a Health Canada guidance document written for synthetic copies of a biologic peptide.

Our read: the approval is a regulator’s judgment on chemistry, impurities and the pen, backed by Ozempic’s own trial record. That is how generic approvals usually work. It is reasonable to trust it, and also reasonable to ask your pharmacist questions when you switch.

Synthetic vs biologic semaglutide: does it matter?

For the molecule, the evidence says no. Both monographs list the same chemical formula, C187 H291 N45 O59, and the same molecular mass.^3,4

What differs is the factory process. Ozempic’s semaglutide is “produced by recombinant DNA technology” in a yeast called Saccharomyces cerevisiae.⁴ Apo-Semaglutide and the Dr. Reddy’s product are made by solid-phase synthetic chemistry, which builds the peptide one piece at a time.^3,6

Health Canada’s spokesperson described this same split in January, biological process for Novo and chemical synthesis for the generics.⁷

The inactive ingredients barely change. Both list disodium phosphate dihydrate, phenol, propylene glycol and water for injections, and the Apo product may add a pH adjuster.^3,4

Recalls happen on both sides

Making a drug a new way raises a fair question about purity. Recalls show that problems get caught on both sides of the brand line.

In June 2025, Health Canada announced a Type II recall of Ozempic pens (DIN 02471469) for cracked glass cartridges.⁸ In August 2026, Dr. Reddy’s recalled eight lots of its generic for an out-of-specification impurity.⁹

Apotex has had two lot-specific recalls tied to the dose shown in the pen window.^10,11 None of these is a reason to avoid a product as a whole, but each is a reason to check your lot number.

The generic pens are not the same as Ozempic pens

The pen is the part you will notice. Concentrations differ by maker, and the Apo starter pen does not match most of the others.

In Ontario, every generic pen sits in a group with the Ozempic pen that matches its strength.¹² Aspen and Sandoz also use 1.34 mg/mL for their starter pens.¹³ Ozempic itself comes in six pen variants, including 1.5 mL and 3 mL cartridges.⁴

Read the dose counter, not the clicks

Apotex says its instructions for use are consistent with brand-name semaglutide.¹⁴ Its starter pen “can dial up to a maximum of 0.5 mg”.³

The monograph tells users to read the dose counter and pointer, and to “not count the pen clicks”.³ Ask your pharmacist to walk you through the new pen before your first dose on it.

No generic 2 mg dose

No generic pen delivers 2 mg.¹³ The Apo-Semaglutide monograph says plainly that “an alternative product will be required” for a 2 mg weekly dose.³

Ozempic’s 2 mg-dose pen (DIN 02523930) shows in Health Canada’s database as approved, with no market date.¹³ If you need it, ask your pharmacy whether it can order one.

What stays the same day to day

On generic semaglutide vs Ozempic, your weekly routine does not change. Both monographs say to inject once a week, at any time of day, with or without meals.^3,4 You can move your injection day if the two doses are at least two days apart.^3,4

Storage is close to identical too. Before first use, both pens go in the fridge at 2 to 8°C and must not freeze. Once in use, each pen lasts 8 weeks in the fridge or at room temperature up to 30°C.^3,4

Needles are one small catch. The Ozempic pen is designed for NovoFine needles, and the Apo-Semaglutide pen for Nano needles.^3,4 Each box comes with needles, but if you buy extras, ask your pharmacist which ones fit.

The price gap between generic and Ozempic

On price, generic semaglutide vs Ozempic is not close: the generic costs about a third of the brand at the cheapest counters. Cash prices at each chain sit in the table below.

The cheapest generic in that table starts at $92 at Costco Pharmacy, while Ozempic starts at $262. That gap is $170 per four-week pen, or about $2,210 over 13 pens in a year. These pharmacy figures come from a published August 2026 retail audit where marked “Audited”, and are estimates where marked “Estimated”.

Public plans show the same pattern. The Ontario Drug Benefit formulary lists the generic at $78.14 per pen and Ozempic at $227.94, so the generic is 34% of the brand.¹² Ontario pays only the generic price, even when Ozempic is dispensed.¹²

Interchangeable: can your pharmacist switch you?

Yes, in provinces that list the generic as interchangeable with Ozempic. Ontario and Alberta both do.

Ontario listed the generics as interchangeable on June 30, 2026.¹² Alberta lists them as interchangeable and says generic semaglutide “is considered equally safe and effective as Ozempic”.¹⁵ After that, substitution at the counter follows each province’s rules and each plan’s policy.^15,16

Private plans add their own rules.

Take Medavie Blue Cross. Members with mandatory generic substitution must pay the cost difference to stay on Ozempic, even if the prescription says “no substitution”.¹⁶ It also accepts exception requests for adverse effects.¹⁶

Manulife and Sun Life have said patients would be moved to the generic, or reimbursed at its price, once their province rules on interchangeability.¹⁷ Our generic semaglutide coverage guide goes province by province.

Switching from Ozempic to the generic

Plan the switch with your prescriber and pharmacist. Here is what a careful switch looks like.

1. Talk to your prescriber first. They decide whether a switch suits you and which dose you take. Do not change your dose on your own.
2. Expect the dose your prescriber writes. Switching brands is not a dose change. The monograph’s dose steps are the same for both products.^3,4
3. Ask for a pen demo. The generic pen can look and dial differently, so have your pharmacist show you how it works.
4. Check the lot number. Compare the lot on your box against Health Canada’s recall notices before you inject.^10,11
5. Watch for side effects as you normally would. If anything new starts after the switch, tell your pharmacist.

Supply matters too. Health Canada’s database still lists Dr. Reddy’s pens as “Marketed”, yet the company reported a shortage in July 2026.^13,18

Ask which generic your pharmacy actually has. For Apotex’s product, our Apo-Semaglutide guide lists both DINs.

Do side effects differ between generic and brand?

Both monographs print the same side-effect rates and the same serious warnings, because both draw on Ozempic’s trials.^3,4 We found no published study comparing side effects of a generic and Ozempic in patients.

The Ozempic monograph is newer, from July 2026. It lists a couple of items the May 2026 Apo-Semaglutide monograph does not, such as “change in skin sensation”.^3,4 Our page on generic Ozempic side effects covers what to expect when starting or switching.

Who might stay on brand Ozempic

Our read: most people on 1 mg or less gain little from the brand beyond familiarity. A few groups have real reasons to stay.

• You need 2 mg a week. No generic delivers that dose.³
• Your prescriber relies on Ozempic’s heart or kidney indications. Those indications appear in Ozempic’s monograph, not the Apo-Semaglutide one.^3,4 Ask your prescriber whether that matters for you.
• Your plan pays for the brand at no extra cost. Check before assuming you would save anything.
• Novo’s savings card brings your cost down. Novo Nordisk launched a card in May 2026 for uninsured people who choose Ozempic. Novo says the card brings their cost in line with the generics.^19,20 It does not apply in Quebec or to public plans.^20,21 Our Ozempic Savings Card guide explains how it works.
• You have had a reaction you link to the switch. Medavie, for one, accepts exception requests for adverse effects.¹⁶

Generic semaglutide vs Ozempic: what to do next

Most people on 0.25, 0.5 or 1 mg a week for type 2 diabetes can expect the same medicine at a lower price. Health Canada’s approval, Ontario’s and Alberta’s interchangeability listings and the matching monographs all point the same way.^1,12,15

Our take: switch with your prescriber’s agreement, learn the new pen, and check your lot number. Stay on Ozempic if you need 2 mg, if your plan covers it fully, or if your prescriber has a clinical reason. To compare costs and pharmacies near you, answer three questions in the find-my-route quiz.